98
Participants
Start Date
April 3, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Etidronate
The dosage of etidronate is 20 mg/kg for twee weeks and ten weeks off. Etidronate is given in capsules of 200 mg. Etidronate capsules are administered orally. During the study, participants will receive etidronate in four periods of two weeks during the twelve months of follow-up.
Placebo
Placebo is given in capsules and are administered orally. During the study, participants will receive placebo in four periods of two weeks during the twelve months of follow-up.
RECRUITING
University Medical Center Utrecht, Utrecht
NOT_YET_RECRUITING
University College London Hospital, London
Netherlands Brain Foundation
OTHER
UMC Utrecht
OTHER